{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:48:37Z","timestamp":1788400117548,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00392-023-02235-y","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T17:01:34Z","timestamp":1687194094000},"page":"1322-1330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Upstream anticoagulation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-4847","authenticated-orcid":false,"given":"Francisco","family":"Albuquerque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"de Ara\u00fajo Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro M.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Presume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Campante","family":"Teles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"de Sousa Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"issue":"3","key":"2235_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7861\/clinmedicine.16-3-277","volume":"16","author":"T Choudhury","year":"2016","unstructured":"Choudhury T, West NE, El-Omar M (2016) ST elevation myocardial infarction. Clin Med (Lond) 16(3):277\u2013282. https:\/\/doi.org\/10.7861\/clinmedicine.16-3-277","journal-title":"Clin Med"},{"issue":"7","key":"2235_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/0735-1097(95)00108-g","volume":"25","author":"WD Weaver","year":"1995","unstructured":"Weaver WD (1995) Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol 25(7 Suppl):3S\u20139S. https:\/\/doi.org\/10.1016\/0735-1097(95)00108-g","journal-title":"J Am Coll Cardiol"},{"issue":"9030","key":"2235_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0140-6736(96)02514-7","volume":"348","author":"E Boersma","year":"1996","unstructured":"Boersma E, Maas AC, Deckers JW, Simoons ML (1996) Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348(9030):771\u2013775. https:\/\/doi.org\/10.1016\/S0140-6736(96)02514-7","journal-title":"The Lancet"},{"issue":"6","key":"2235_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/s0735-1097(03)00919-7","volume":"42","author":"G De Luca","year":"2003","unstructured":"De Luca G, Suryapranata H, Zijlstra F et al (2003) Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42(6):991\u2013997. https:\/\/doi.org\/10.1016\/s0735-1097(03)00919-7","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2235_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jacc.2005.06.054","volume":"46","author":"G Tarantini","year":"2005","unstructured":"Tarantini G, Cacciavillani L, Corbetti F et al (2005) Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol 46(7):1229\u20131235. https:\/\/doi.org\/10.1016\/j.jacc.2005.06.054","journal-title":"J Am Coll Cardiol"},{"key":"2235_CR6","doi-asserted-by":"publisher","unstructured":"Ib\u00e1nez B, James S, Agewall S, et al (2017) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol (Engl Ed) 70(12):1082. https:\/\/doi.org\/10.1016\/j.rec.2017.11.010","DOI":"10.1016\/j.rec.2017.11.010"},{"issue":"11","key":"2235_CR7","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIR.0000000000000336","volume":"133","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Blankenship JC et al (2016) 2015 ACC\/AHA\/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the society for cardiovascular angiography and interventions. Circulation 133(11):1135-1147. https:\/\/doi.org\/10.1161\/CIR.0000000000000336","journal-title":"Circulation"},{"issue":"1","key":"2235_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12959-015-0061-1","volume":"13","author":"CH Hansen","year":"2015","unstructured":"Hansen CH, Ritschel V, Halvorsen S et al (2015) Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction. Thromb J 13:31. https:\/\/doi.org\/10.1186\/s12959-015-0061-1","journal-title":"Thromb J"},{"issue":"1","key":"2235_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1538-7836.2007.02799.x","volume":"6","author":"K Brummel-Ziedins","year":"2008","unstructured":"Brummel-Ziedins K, Undas A, Orfeo T et al (2008) Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost 6(1):104\u2013110. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02799.x","journal-title":"J Thromb Haemost"},{"key":"2235_CR10","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3(3):e123\u2013e130","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2235_CR11","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M et al (2023) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"2235_CR12","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (2022) Cochrane handbook for systematic reviews of interventions version 6.3. Cochrane Available from https:\/\/www.training.cochrane.org\/handbook"},{"issue":"10","key":"2235_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/ehjacc\/zuab032","volume":"10","author":"JE Bloom","year":"2021","unstructured":"Bloom JE, Andrew E, Nehme Z et al (2021) Pre-hospital heparin use for ST-elevation myocardial infarction is safe and improves angiographic outcomes. Eur Heart J Acute Cardiovasc Care 10(10):1140\u20131147. https:\/\/doi.org\/10.1093\/ehjacc\/zuab032","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"3","key":"2235_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ccd.28540","volume":"96","author":"WJ Cantor","year":"2020","unstructured":"Cantor WJ, Lavi S, D\u017eav\u00edk V et al (2020) Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the TOTAL trial. Catheter Cardiovasc Interv 96(3):519\u2013525. https:\/\/doi.org\/10.1002\/ccd.28540","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"2235_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4244\/EIJ-D-22-00432","volume":"18","author":"OE Emilsson","year":"2022","unstructured":"Emilsson OL, Bergman S, Mohammad MA et al  (2022) Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention 18(9):709\u2013718. https:\/\/doi.org\/10.4244\/EIJ-D-22-00432","journal-title":"EuroIntervention"},{"key":"2235_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijcard.2015.06.009","volume":"198","author":"T Giralt","year":"2015","unstructured":"Giralt T, Carrillo X, Rodriguez-Leor O et al (2015) Time-dependent effects of unfractionated heparin in patients with ST-elevation myocardial infarction transferred for primary angioplasty. Int J Cardiol 198:70\u201374. https:\/\/doi.org\/10.1016\/j.ijcard.2015.06.009","journal-title":"Int J Cardiol"},{"key":"2235_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijcard.2020.09.058","volume":"325","author":"T Giralt","year":"2021","unstructured":"Giralt T, Ribas N, Freixa X et al (2021) Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: Does time matter?. Int J Cardiol 325:9\u201315. https:\/\/doi.org\/10.1016\/j.ijcard.2020.09.058","journal-title":"Int J Cardiol"},{"issue":"1","key":"2235_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/2048872617727723","volume":"8","author":"S Karlsson","year":"2019","unstructured":"Karlsson S, Andell P, Mohammad MA et al (2019) Editor's choice- heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial. Eur Heart J Acute Cardiovasc Care 8(1):15\u201323. https:\/\/doi.org\/10.1177\/2048872617727723","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"2","key":"2235_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/FJC.0000000000000865","volume":"76","author":"C McGinley","year":"2020","unstructured":"McGinley C, Mordi IR, Kell P et al (2020) Prehospital administration of unfractionated heparin in ST-segment elevation myocardial infarction is associated with improved long-term survival. J Cardiovasc Pharmacol. 76(2):159\u2013163. https:\/\/doi.org\/10.1097\/FJC.0000000000000865","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"2235_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/01.CIR.79.2.441","volume":"79","author":"E Braunwald","year":"1989","unstructured":"Braunwald E (1989) Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?. Circulation 79(2):441\u2013444. https:\/\/doi.org\/10.1161\/01.cir.79.2.441","journal-title":"Circulation"},{"key":"2235_CR21","doi-asserted-by":"publisher","unstructured":"GUSTO investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329(10):673\u2013682. https:\/\/doi.org\/10.1056\/NEJM199309023291001","DOI":"10.1056\/NEJM199309023291001"},{"key":"2235_CR22","doi-asserted-by":"publisher","unstructured":"Berger PB, Ellis SG, Holmes DR Jr et al (1999) Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 100(1):14\u201320. https:\/\/doi.org\/10.1161\/01.cir.100.1.14","DOI":"10.1161\/01.cir.100.1.14"},{"issue":"7","key":"2235_CR23","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/0735-1097(96)00053-8","volume":"27","author":"L Kristin Newby","year":"1996","unstructured":"Newby LK, Rutsch WR, Califf RM et al (1996) Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol 27(7):1646\u20131655. https:\/\/doi.org\/10.1016\/0735-1097(96)00053-8","journal-title":"J Am Coll Cardiol"},{"key":"2235_CR24","doi-asserted-by":"publisher","unstructured":"Terkelsen CJ, S\u00f8rensen JT, Maeng M et al (2010) System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 304(7):763\u2013771. https:\/\/doi.org\/10.1001\/jama.2010.1139","DOI":"10.1001\/jama.2010.1139"},{"issue":"15","key":"2235_CR25","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","volume":"368","author":"PW Armstrong","year":"2013","unstructured":"Armstrong PW, Gershlick AH, Goldstein P et al (2013) Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 368(15):1379\u20131387. https:\/\/doi.org\/10.1056\/NEJMoa1301092","journal-title":"N Engl J Med"},{"issue":"7","key":"2235_CR26","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/hq0701.093686","volume":"21","author":"J Hirsh","year":"2001","unstructured":"Hirsh J, Anand SS, Halperin JL, Fuster V (2001) Mechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol 21(7):1094\u20131096. https:\/\/doi.org\/10.1161\/hq0701.093686","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"17","key":"2235_CR27","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","volume":"369","author":"O Fr\u00f6bert","year":"2013","unstructured":"Fr\u00f6bert O, Lagerqvist B, Olivecrona GK et al  (2014) Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587\u20131597. https:\/\/doi.org\/10.1056\/NEJMoa1308789","journal-title":"N Engl J Med"},{"issue":"15","key":"2235_CR28","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","volume":"372","author":"SS Jolly","year":"2015","unstructured":"Jolly SS, Cairns JA, Yusuf S et al (2015) Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med 372(15):1389\u20131398. https:\/\/doi.org\/10.1056\/NEJMoa1415098","journal-title":"N Engl J Med"},{"issue":"15","key":"2235_CR29","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/eurheartj\/ehz069","volume":"40","author":"B Redfors","year":"2019","unstructured":"Redfors B, Dworeck C, Haraldsson I et al (2019) Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 40(15):1202\u20131210. https:\/\/doi.org\/10.1093\/eurheartj\/ehz069","journal-title":"Eur Heart J"},{"issue":"11","key":"2235_CR30","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","volume":"371","author":"G Montalescot","year":"2014","unstructured":"Montalescot G, van 't Hof AW, Lapostolle F et al (2014) Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med 371(11):1016\u20131027. https:\/\/doi.org\/10.1056\/NEJMoa1407024","journal-title":"N Engl J Med"},{"issue":"6","key":"2235_CR31","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1253\/circj.71.862","volume":"71","author":"WY Chung","year":"2007","unstructured":"Chung WY, Han MJ, Cho YS et al (2007) Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty. Circ J 71(6):862\u2013867. https:\/\/doi.org\/10.1253\/circj.71.862","journal-title":"Circ J"},{"issue":"8","key":"2235_CR32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/s0828-282x(07)70229-5","volume":"23","author":"D Fitchett","year":"2007","unstructured":"Fitchett D (2007) The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the risk. Can J Cardiol 23(8):663\u2013671. https:\/\/doi.org\/10.1016\/s0828-282x(07)70229-5","journal-title":"Can J Cardiol"},{"issue":"8","key":"2235_CR33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","volume":"114","author":"JW Eikelboom","year":"2006","unstructured":"Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114(8):774\u2013782. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.612812","journal-title":"Circulation"},{"issue":"11","key":"2235_CR34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045\u20131057. https:\/\/doi.org\/10.1056\/NEJMoa0904327","journal-title":"N Engl J Med"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02235-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02235-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02235-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T14:13:23Z","timestamp":1692886403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02235-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2235"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02235-y","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"12 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial or non-financial conflicts of interest related to the work submitted for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}